Compounds > ambroxol
Page last updated: 2024-10-22

ambroxol and Carcinoma, Non-Small Cell Lung

ambroxol has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, JY1
Hong, X1
Chen, GH1
Li, QC1
Liu, ZM1
Li, J1
Yi, W1
Jiang, P1
Sun, R1
Li, T1

Trials

1 trial available for ambroxol and Carcinoma, Non-Small Cell Lung

ArticleYear
Mucosolvan serves to optimize perioperative airway management for NSCLC patients in fast track surgery: a randomized placebo controlled study.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:15

    Topics: Aged; Airway Management; Ambroxol; Carcinoma, Non-Small-Cell Lung; Expectorants; Female; Humans; Len

2015

Other Studies

1 other study available for ambroxol and Carcinoma, Non-Small Cell Lung

ArticleYear
Effects of ambroxol hydrochloride on concentrations of paclitaxel and carboplatin in lung cancer patients at different administration times.
    Cellular and molecular biology (Noisy-le-Grand, France), 2016, Nov-30, Volume: 62, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Ambroxol; Antineoplastic Combined Chemotherapy Protocols; Carboplati

2016